Viewing Study NCT00440635

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:45 PM

Ignite Modification Date: 2025-12-30 @ 10:35 AM

Study NCT ID: NCT00440635

Status: COMPLETED

Last Update Posted: 2013-04-16

First Post: 2007-02-26

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma

Sponsor: Janssen-Cilag International NV

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module